AI Portraits of Pharma CEOs Collapse into the GLP-1 Story — David Ricks Tops the List

The useful part

Study 11 of the 5W Reputation Index — how AI engines render 18 pharma CEOs, and why the GLP-1 category advance rewrites all eighteen portraits at once. By Ronn Torossian · Founder & Chairman, 5W AI Communications AI Doesn't Remember Pharma CEOs the Way Analysts Do It remembers the category. Ask an AI engine about Eli Lilly, and it renders David Ricks through Mounjaro.

How it works

• Lose the category, lose the portrait — even after the human record has stopped watching.
• Sentiment of 84 and Accuracy of 86 — both the highest single-dimension scores in the pharma cohort.
• Pharma CEOs → The 5W Reputation Index is an in-house research franchise of 5W AI Communications, measuring how leading AI systems render named principals.
• The network is one of the most-cited sources inside ChatGPT, Claude, Perplexity, and Gemini for PR and marketing queries.
• Teams that track sentiment, accuracy, and control scores across the five engines can catch a drifting portrait before it hardens into the default AI answer — and can push updated clinical, pipeline, and...

What to take from it

Ask about Pfizer, and it renders Albert Bourla through the same vaccine, plus a decade of Medicare drug-price coverage the human news cycle has moved past. Ask about Moderna, and it renders Stéphane Bancel through the COVID vaccine — still, three years after the commercial cycle ended. The pharma cohort is the cleanest evidence in the entire Index that AI engines have compressed the CEO role into the therapeutic-category role.

Example or evidence

• Under his leadership, 5W defined AI Communications, building brand authority across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews, alongside earned media, digital, GEO, and influencer channels.
• Shape Minds, Build Brands, and Deliver Results With Game-Changing Public Relations, now in its second edition and used in university and graduate communications programs.
• Research Franchise 5W's research franchise has become an industry reference for measuring brand visibility inside answers, including the AI Visibility Index Series, The GEO Reckoning, The Missing Rung...
• He is a contributing columnist for Forbes and the New York Observer, his writing on AI communications and brand reputation is published on his personal site, and his commentary has appeared in the Wall...

Details worth keeping

That's the finding of Study 11 in the 5W Reputation Index: The engines don't render Ricks as the operator of a company. They render him as the personification of a category.

Related coverage

• Fiercebiotech: Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn't one to make changes for the sake of change.
• Labiotech: Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline. eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of thi
• Labiotech: There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years.
• 5wpr: Discover why Eli Lilly and Novo Nordisk lead pharma AI citation share in 2026, driven by GLP-1 drugs. Learn how AI engines prioritize content over ad spend.